Using wearable devices to improve health in high-risk stroke patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of smart wearable devices in managing key risk factors for stroke among high-risk populations. It is a randomized controlled trial that focuses on how features like medication reminders, heart rate monitoring, and exercise prompts can improve conditions such as hypertension, diabetes, and dyslipidemia. Participants will be monitored to assess changes in their health metrics, particularly blood pressure, blood glucose, and blood lipids, as a result of using these devices.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Diagnosed with hypertension;
2. Diagnosed with diabetes;
3. Diagnosed with atrial fibrillation;
4. Smoking subjects;
5. Physical inactive subjects；
6. Obesity and overweight subjects;
7. Must be able to use smart wearable devices.

Exclusion Criteria:

1. Diagnosed with malignancies;
2. Diagnosed with psychiatric disorders;
3. Diagnosed with cognitive impairment;
4. Unable to operate smart wearable devices.

Where it's running

• Affiliated Hospital of Nantong University
  Nantong, Jiangsu, China Recruiting

Study contacts

• Study coordinator: Qiuhong Ji, MD, PhD
• Email: jiqiuhong@ntu.edu.cn
• Phone: +8613962916293

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart, kidney, and metabolic health in Shanghai community residents

  This follow-up will track people from the STONE cohort to see if changes in metabolic risk factors over time relate to heart and kidney outcomes.

  Recruiting Shanghai Changzheng Hospital · Shanghai, Shanghai Municipality · NCT07043166

• Polypill Approach for Multiple Cardiovascular Risk Factors

  Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.

  Recruiting at 5 sites China Medical University, China · Zhengzhou, Henan and 14 other locations · NCT07679828

• Inspire HER: a heart-health and stress-support program for Black women

  This project will test whether the Inspire HER lifestyle program helps Black women with higher heart disease risk improve heart health and manage stress.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT06966258

• Program to prevent young onset diabetes using genetic and clinical assessments

  This study is testing a program that uses genetic and health checks to help young adults at risk of diabetes prevent the disease and learn more about their health.

  Recruiting Asia Diabetes Foundation · Hong Kong · NCT06693934

• Mobile health outreach for men's cancer screening

  This study is testing a mobile health service that brings cancer screening directly to men at their workplaces, especially those in high-risk groups, to help them get checked for prostate cancer and other urological issues.

  Recruiting Royal Marsden NHS Foundation Trust · London · NCT06357416

• Two-drug interaction study of UIC202601 and UIC202602 in healthy adults

  This study tests whether combining two investigational drugs changes how they behave in the body and whether the combination is safe in healthy volunteers.

  Recruiting Phase 1 Korea United Pharm. Inc. · Anyang, Manan-gu · NCT07682948

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.